What is the ticker symbol for Eupraxia Pharmaceuticals?

Eupraxia Pharmaceuticals trades under the ticker EPRX on NASDAQ.

What sector does Eupraxia Pharmaceuticals operate in?

Eupraxia Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze EPRX in a portfolio?

PortView shows EPRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Eupraxia Pharmaceuticals (EPRX) Stock Analysis

NASDAQHealthcareBiotechnology

$7.01+10.57%

1-year price historyRange $5.27 – $9.07

52-week range$7.01

$5.15$9.32

What Eupraxia Pharmaceuticals does

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company's product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of gastrointestinal tract, such as eosinophilic esophagitis. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.

Key metrics

Market cap

$234.69M

P/E (TTM)

-6.68

EPS (TTM)

$-1.05

Beta

1.50

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$6.59

200-day avg

$7.11

52-week high

$9.32

52-week low

$5.15

CEO

James A. Helliwell

ETFs linked to EPRX

Broad-market and Healthcare sector ETFs an investor holding Eupraxia Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how EPRX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze EPRX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Eupraxia Pharmaceuticals?: Eupraxia Pharmaceuticals trades under the ticker EPRX on NASDAQ.
Which exchange is EPRX listed on?: EPRX is listed on NASDAQ.
What sector does Eupraxia Pharmaceuticals operate in?: Eupraxia Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze EPRX in a portfolio?: PortView shows EPRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.